Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Even though peptides can work quickly, many patients use them as part of a longer-term wellness or longevity plan
In a subset of patients, they saw a slight decrease in some Alzheimers biomarkers, proteins that can indicate presence of the disease
In fact, Zepbound, a medication with the same active ingredient, was FDA approved for weight management in 2023
After twelve weeks, you will not remember exactly where you injected on week three
The best choice varies from person to person